The 2,4,6‐tris(2‐pyridyl)‐1,3,5‐triazine (tptz) undergoes hydrolysis in the presence of VO(SO4) in an alkaline solution, affording mainly the bis(2‐pyridyl carbonyl)amid) VO2 complex, designated as [VO2(bpca)]. Single‐crystal X‐ray crystallography revealed that the coordination of V in complex is a distorted square‐pyramid coordinated with three nitrogen of bis(2‐pyridyl carbonyl)amid) ligand and two binding oxygen atoms. The prepared complex which successfully supported on modified Fe3O4 nanoparticles using tetraethylorthosilicate (TEOS) and (3‐aminopropyl)trimethoxysilane(APTMS)was designated as Fe3O4@SiO2@APTMS@[VO2(bpca)] complex (nanocatalyst). The complex and nanocatalyst were characterized by means of FT‐IR, XRD, VSM, SEM and TEM. The catalytic activity of [VO2(bpca)] complex and Fe3O4@SiO2@APTMS@complex as catalysts 1 and 2 were evaluated by the epoxidation of geraniol, 3‐methyl‐2‐buten‐1‐ol, trans‐2‐hexen‐1‐ol and 1‐octen‐3‐ol with 70–98% conversions and 95–100% selectivities. Based on the obtained results, the heterogeneity and reusability of the catalyst seems promising. In addition, the in vitro antibacterial activity of [VO2 (bpca)] complex have also been evaluated and compared to the activities of other vanadium complexes, tptz ligand and two standard antibacterial drugs, Nalidixic acid and Vancomycin.